Selvatici R, Orlando P, Rubini M, Balboni A, Balugani S, Gandini E
Istituto di Genetica Medica, Università di Ferrara, Italy.
Biochem Int. 1991 Jan;23(1):53-8.
N-N-Staurosporine (STAR) inhibits in a dose dependent manner Tritiated-Thymidine (3H-TdR) incorporation in phytohemagglutinin (PHA) activated Peripheral Blood Mononuclear Cells (PBMC) treated with anti-HLA class I monoclonal antibody (MAb) 01.65 and its effect results competitive with MAb 01.65. Cytosolic and particulate Protein Kinase C (PKC) have been studied. Only when PKC particulate activity is no more detectable, the effect of STAR on 3H-TdR incorporation is evident.
N-N-星孢菌素(STAR)以剂量依赖性方式抑制用抗HLA I类单克隆抗体(MAb)01.65处理的植物血凝素(PHA)激活的外周血单个核细胞(PBMC)中氚标记胸腺嘧啶核苷(3H-TdR)的掺入,其作用与MAb 01.65具有竞争性。已对细胞溶质和颗粒性蛋白激酶C(PKC)进行了研究。只有当PKC颗粒活性不再可检测到时,STAR对3H-TdR掺入的作用才明显。